Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
31
1
2
3
4
5
6
8
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
31
1
2
3
Bruker Corporation to Present at the 37th Annual J.P. Morgan Healthcare Conference
Bruker Corporation (NASDAQ: BRKR) announced today it will participate in the 37th annual J.P. Morgan Healthcare Conference in San Francisco. Frank Laukien, Chairman, President & CEO and Gerald Herman, CFO [...]
Allergan to Present at the 37th Annual J.P. Morgan Healthcare Conference
2019-01-07    
3:30 pm
Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, today announced that Chairman and CEO Brent Saunders will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, [...]
Johnson & Johnson to Participate in 37th Annual JP Morgan Health Care Conference
2019-01-07    
3:30 pm
Johnson & Johnson (NYSE: JNJ) will participate in the 37th Annual JP Morgan Health Care Conference on Monday, Jan. 7th, at the Westin St. Francis in San Francisco.  Joseph J. [...]
Halozyme Therapeutics To Present At The 37th Annual J.P. Morgan Healthcare Conference
2019-01-09    
10:30 am
Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, will be presenting at the 37th Annual J.P. Morgan Healthcare Conference in San [...]
International Conference on Chemistry, Chemical Engineering and Chemical Process
2019-01-30 - 2019-01-31    
All Day
It is a great pleasure and an honor to extend to you a warm invitation to attend the "International Conference on Chemistry, Chemical Engineering and [...]
Streamline HCP Workflow • Drive Patient Education • Navigate the Specialty Prescribing Landscape
2019-02-01    
12:00 am
The original and most comprehensive conference series dedicated entirely to strategies for effective utilization of e-Rx and EHR technologies is back for 2019. Whether new [...]
Articles News

A study shows that AI can detect suicide risk early.

EMR Industry

As artificial intelligence helps doctors discover diseases like cancer at an early stage, it is also demonstrating its potential in tackling mental health crises. According to one study, artificial intelligence can detect patients who are at danger of suicide, providing a tool for prevention in everyday medical settings.

The study, published in the JAMA Network Open Journal, examined two approaches of notifying doctors about suicide risk: an active “pop-up” alarm demanding immediate attention and a passive system (less urgent) that displays risk information in a patient’s electronic chart.

The study discovered that active warnings beat the passive strategy, encouraging doctors to assess suicide risk in 42% of cases, against only 4% with the passive system. Furthermore, it emphasized the importance of using certain techniques to initiate a discourse about suicide risks.

This breakthrough, which combines automated risk identification with deliberately tailored alarms, provides hope for identifying and supporting more people in need of suicide prevention services.

Colin Walsh, an Associate Professor of Biomedical Informatics, Medicine, and Psychiatry at Vanderbilt University Medical Center, emphasized the importance of this breakthrough. “Most people who die by suicide have seen a healthcare provider in the year before their death, often for reasons unrelated to mental health,” according to Walsh.

Previous research indicates that 77% of people who commit suicide had contact with primary care doctors in the year before their death. These findings highlight the essential role AI can play in bridging the gap between conventional medical treatment and mental health interventions.

The Suicide Attempt and Ideation Likelihood model (VSAIL), an AI-driven system developed at Vanderbilt, was tested in three neurology clinics. The method uses normal data from electronic health records to calculate a patient’s 30-day probability of attempting suicide. When high-risk patients were identified, practitioners were encouraged to start focused conversations about mental health.

Walsh clarified: “Universal screening isn’t practical everywhere, but VSAIL helps us focus on high-risk patients and spark meaningful screening conversations.”

While the findings were promising, the researchers emphasized the importance of striking a balance between the benefits of active alerts and their possible drawbacks, such as workflow disruption. The authors proposed that comparable methods may be implemented for other medical specialties in order to broaden their reach and impact.

Cambridge University published a research earlier in 2022 that used PRISMA criteria to assess individuals who were at risk of attempting suicide.